The cognitive enhancement provided by insulin in both healthy and diseased individuals, as well as its various positive effects on conditions such as dementia and Alzheimer’s disease, is related to its direct impact on the cerebellar and hippocampal regions of the brain through IN administration [20]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.